Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Novel triazole antifungal agents.

H L Hoffman1, E J Ernst, M E Klepser

  • 1University of Iowa, S412 Pharmacy Building, Iowa City, IA 52242-1112, USA.

Expert Opinion on Investigational Drugs
|November 4, 2000
PubMed
Summary

New antifungal triazole agents show promise for treating serious fungal infections in immunocompromised patients. Voriconazole, posaconazole, and ravuconazole offer improved activity against resistant Candida species and Aspergillus.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Quality and extent of implementation of a nurse-led care management intervention: care coordination for health promotion and activities in Parkinson's disease (CHAPS).

BMC health services research·2020
Same author

Pharmacy-Based Infectious Disease Management Programs Incorporating CLIA-Waived Point-of-Care Tests.

Journal of clinical microbiology·2020
Same author

Factors that influence the variability in findings of anogenital injury in adolescent/adult sexual assault victims: a review of the forensic literature.

The American journal of forensic medicine and pathology·2013
Same author

Analysis of possible sexual assault or abuse in a 67-year-old female with early dementia post-brain attack.

Advanced emergency nursing journal·2013
Same author

Correlates of Adherence among Rural Indian Women Living with HIV/AIDS.

Journal of HIV/AIDS & social services·2013
Same author

The element of naturalness when evaluating image quality of digital photo documentation after sexual assault.

Advanced emergency nursing journal·2012

Area of Science:

  • Mycology
  • Infectious Diseases
  • Pharmacology

Background:

  • Immunocompromised patients face increased risk of opportunistic fungal infections.
  • Candida albicans is a common pathogen, but non-albicans species and other fungi like Aspergillus are emerging threats.
  • Existing triazole antifungals (fluconazole, itraconazole) have limitations in spectrum and bioavailability.

Purpose of the Study:

  • To review and compare new triazole antifungal agents.
  • To address the need for improved antifungal therapies due to rising fungal infections and resistance.
  • To evaluate voriconazole, posaconazole, and ravuconazole against existing treatments.

Main Methods:

  • Review of preclinical and clinical trial data for new triazole antifungals.
  • Comparative analysis of voriconazole, posaconazole, and ravuconazole efficacy and spectrum.
  • Assessment of limitations of current antifungal agents like fluconazole and itraconazole.

Main Results:

  • New triazole agents demonstrate potential for broader antifungal activity.
  • Voriconazole, posaconazole, and ravuconazole show promise in overcoming limitations of older drugs.
  • Emerging fungal pathogens necessitate development of novel antifungal strategies.

Conclusions:

  • New triazole antifungals are needed to combat rising incidence of invasive fungal infections.
  • Voriconazole, posaconazole, and ravuconazole represent promising advancements in antifungal therapy.
  • Further clinical evaluation is essential for these novel agents to improve patient outcomes.

Related Experiment Videos